InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Sheikh Michael, Chairman & CEO. Officer active across 1 company, notably Bioxytran, INC. Aggregated, 7 disclosures have been logged. Activity tracked since 4 June 2021. The latest transaction was filed on 24 October 2024 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Michael K. Hargrave serves as Chief Executive Officer and Executive Vice President at BIOXYTRAN, INC. He leads the company with a strategic vision, focusing on growth and innovation. His role involves overseeing daily operations and formulating strategies to maximize shareholder value.